Role of dopamine D3 receptors in the addictive properties of ethanol

Drugs of Today

Volumn 40, Issue 4, 2004, Pages 355-365

  Heidbreder, Christian A ^a   Andreoli, Michela ^a   Marcon, Clara ^a   Thanos, Panayotis K ^b   Ashby Jr , Charles R ^c   Gardner, Eliot L ^d  

^a GSK   (Italy)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DRD3 PROTEIN, HUMAN; LIGAND;

ALCOHOLISM; CLINICAL RESEARCH; DNA POLYMORPHISM; DOPAMINE RELEASE; DRUG DEPENDENCE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; REVIEW; ADDICTION; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; HUMAN; LIMBIC SYSTEM; METABOLISM; NUCLEUS ACCUMBENS; PHYSIOLOGY; REWARD; WITHDRAWAL SYNDROME;

ALCOHOLISM; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; ETHANOL; HUMANS; LIGANDS; LIMBIC SYSTEM; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REWARD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 2642553382     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2004.40.4.820081     Document Type: Review

References (93)

1. 2 dopamine receptor cDNA. Nature (Lond) 1988, 336: 783-7.
2. 1 receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 1990, 87: 6723-7.
3. 1 dopamine receptors. Nature (Lond) 1990, 347: 72-6.
4. 3) as a target for neuroleptics. Nature (Lond) 1990, 347: 146-51.
5. 1. Nature (Lond) 1991, 350: 614-9.
6. 4 receptor with high affinity for the antipsychotic clozapine. Nature (Lond) 1991, 350: 610-4.
7. Swift, R.M. Drug therapy for alcohol dependence. N Engl J Med 1999, 340: 1482-90.
8. National Household Survey on Drug Abuse. Vol. I. Survey of National Findings. SAMHSA, Rockville 2002, 25-31.
9. McBride, W.J., Li, T.K. Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 1998, 12: 339-69.
10. Di Chiara, G., Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988, 85: 5274-8.
11. Gessa, G.L., Muntoni, F., Collu, M., Vargiu, L., Mereu, G. Low doses of ethanol activate dopaminergic neurons of the ventral tegmental area. Brain Res 1985, 348: 201-3.
12. Budygin, E.A., Phillips, P.E., Wightman, R.M., Jones, S.R. Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: An in vitro voltammetric study. Synapse 2001, 42: 77-9.
13. Yim, H.J., Gonzales, R.A. Ethanol-induced increases in dopamine extracellular concentration in rat nucleus accumbens are accounted for by increased release and not uptake inhibition. Alcohol 2000, 22: 107-15.
14. Ikemoto, S., McBride, W.J., Murphy, J.M., Lumeng, L., Li, T.K. 6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats. Alcohol Clin Exp Res 1997, 21: 1042-6.
15. Koistinen, M., Tuomainen, P., Hyytia, P., Kiianmaa, K. Naltrexone suppresses ethanol intake in 6-hydroxydopamine-treated rats. Alcohol Clin Exp Res 2001, 25: 1605-12.
16. Engleman, E.A., McBride, W.J., Wilber, A.A. et al. Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcohol-preferring rats: Effects on dialysate dopamine levels and ethanol intake. Alcohol Clin Exp Res 2000, 24: 795-801.
17. Boileau, I., Assaad, J.M., Pihl, R.O. et al. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 2003, 49: 226-31.
18. Cloninger, C.R., Przybeck, T.R., Svrakic, D.M. The tridimensional personality questionnaire: U.S. normative data. Psychol Rep 1991, 69: 1047-57.
19. Roberts, A.J., Koob, G.F. The neurobiology of addiction: An overview. Alcohol Health Res World 1997, 21: 101-6.
20. Diana, M., Pistis, M., Carboni, S., Gessa, G.L., Rossetti, Z.L. Profound decrement of mesolimbic neuronal activity during ethanol withdrawal syndrome in rats: Electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 1992, 90: 7966-9.
21. Shen, R.Y., Chiodo, L.A. Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area. Brain Res 1993, 622: 289-93.
22. Rossetti, Z.L., Hmaidan, Y., Gessa, G.L. Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol 1992, 221: 227-34.
23. Weiss, F., Parsons, L.H., Schulteis, G. et al. Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and serotonin release in dependent rats. J Neurosci 1996, 16: 3474-85.
24. Diana, M., Pistis, M., Muntoni, A., Gessa, G. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: Evidence of protracted abstinence. Neuroscience 1996, 71: 411-5.
25. Bailey, C.P., Andrews, N., McKnight, A.T., Hughes, J., Little, H.J. Prolonged changes in neurochemistry of dopamine neurones after chronic ethanol consumption. Pharmacol Biochem Behav 2000, 66: 153-61.
26. Heinz, A., Lichtenberg-Kraag, B., Baum, S.S. et al. Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome. J Neural Transm Gen Sect 1995, 102: 149-57.
27. 2 receptor mRNA. Brain Res 1991, 564: 203-19.
28. Curran, E.J., Watson, S.J., Jr. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: A double in situ hybridization study. J Comp Neurol 1995, 361: 57-76.
29. 3 receptor in the rat brain. Neuroscience 1995, 65: 731-45.
30. Diaz, J., Pilon, C., Le Foll, B. et al. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 2000, 20: 8677-84.
31. 3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 1993, 18: 187-92.
32. 3 receptors in islands of Calleja and shell of nucleus accumbens of the rats: Opposite and synergistic functional interactions. Eur J Neurosci 1998, 10: 1676-86.
33. 2 receptor expressing neurons. Neuropsychopharmacology 1999, 20: 60-80.
34. Meador-Woodruff, J.H., Grandy, D.K., Van Tol, H.H. et al. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 1994, 10: 239-48.
35. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 1998, 779: 58-74.
36. 3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims. Ann NY Acad Sci 1999, 877: 507-22.
37. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996, 16: 6100-6.
38. 3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 1997, 45: 335-9.
39. Meador-Woodruff, J.H., Little, K.Y., Damask, S.P., Watson, S.J. Effects of cocaine on D3 and D4 receptor expression in the human striatum. Biol Psychiatry 1995, 38: 263-6.
40. Court, J.A., Lloyd, S., Thomas, N. et al. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998, 87: 63-78.
41. 3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 2002, 15: 2016-26.
42. Le Foll, B., Schwartz, J.C., Sokoloff, P. Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 2003a, 8: 225-30.
43. Le Foll, B., Diaz, J., Sokoloff, P. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 2003b, 47: 176-83.
44. Spangler, R., Goddard, N.L., Avena, N.M., Hoebel, B.G., Leibowitz, S.F. Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Brain Res Mol Brain Res 2003, 111: 74-83.
45. Cloninger, C.R. A systematic method for clinical description and classification of personality variants. Arch Gen Psych 1987, 44: 573-88.
46. Wiesbeck, G.A., Mauerer, C., Thome, J., Jakob, F., Boening, J. Neuroendocrine support for a relationship between novelty seeking and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology 1995, 20: 755-61.
47. Lannfelt, L., Sokoloff, P., Martres, M.P. et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 1992, 2: 249-56.
48. Sander, T., Harms, H., Podschus, J. et al. Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatr Genet 1995, 5: 171-6.
49. Thome, J., Weijers, H.G., Wiesbeck, G.A. et al. Dopamine D3 receptor gene polymorphism and alcohol dependence: Relation to personality rating. Psychiatr Genet 1999, 9: 17-21.
50. Dobashi, I., Inada, T., Hadano, K. Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatr Genet 1997, 7: 87-91.
51. Gorwood, P., Martres, M.P., Ades, J. et al. Lack of association between alcohol-dependence and D3 dopamine receptor gene in three independent samples. Am J Med Genet 1995, 60: 529-31.
52. Gorwood, P., Limosin, F., Batel, P., Duaux, E., Gouya, L., Ades, J. The genetics of addiction: Alcohol dependence and D3 dopamine receptor gene. Pathol Biol (Paris) 2001, 49: 710-7.
53. Higuchi, S., Muramatsu, T., Matsushita, S., Murayama, M. No evidence of association between structural polymorphism at the dopamine D3 receptor locus and alcoholism in the Japanese. Am J Med Genet 1996, 67: 412-4.
54. Lee, M.S., Ryu, S.H. No association between the dopamine D3 receptor gene and Korean alcohol dependence. Psychiatr Genet 2002, 12: 173-6.
55. Parsian, A., Chakraverty, S., Todd, R.D. Possible association between the dopamine D3 receptor gene and bipolar affective disorder. Am J Med Genet 1995, 60: 234-7.
56. Parsian, A., Chakraverty, S., Fisher, L., Cloninger, C.R. No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism. Am J Med Genet 1997, 74: 281-5.
57. Wiesbeck, G.A., Weijers, H.G., Wodarz, N. et al. Dopamine D2 (DAD2) and dopamine D3 (DAD3) receptor gene polymorphisms and treatment outcome in alcohol dependence. J Neural Transm 2003, 110: 813-20.
58. Comings, D.E., Gonzalez, N., Wu, S. et al. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol Psychiatry 1999, 4: 484-7.
59. Li, T., Liu, X., Zhao, J. et al. Allelic association analysis of the dopamine D2, D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects. Am J Genet 2002, 114: 329-35.
60. Retz, W., Rosler, M., Supprian, T., Retz-Junginger, P., Thome, J. Dopamine D3 receptor gene polymorphism and violent behavior: Relation to impulsiveness and ADHD-related psychopathology. J Neural Transm 2003, 110: 561-72.
61. Cloninger, C.R., Sigvardsson, S., Bohman, M. Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res 1988, 12: 494-505.
62. Meszaros, K., Lenzinger, E., Hornik, K. et al. The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group. Alcohol Clin Exp Res 1999, 23: 483-6.
63. Leyton, M., Boileau, I., Benkelfat, C., Diksit, M., Baker, G., Dagher, A. Amphetamine-induced increases in extracellular dopamine, drug wanting and novelty seeking: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002, 27: 1027-35.
64. Cohen, C., Perrault, G., Sanger, D.J. Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice. Neuropharmacology 1997, 36: 1099-1108.
65. Risinger, F.O., Brown, M.M., Oakes, R.A., Love, J.A. Effects of haloperidol and SCH-23390 on ethanol-induced conditioned taste aversion. Alcohol 1999, 18: 139-45.
66. Hutchison, K.E., Swift, R.M., Attias, E., Monti, P., Rohsenow, D. Effects of olanzapine on cue-induced craving in moderate to heavy social drinkers. Alcohol Clin Exp Res 1998, 22: 662A.
67. Modell, J.G., Mountz, J.M., Glaser, F.B., Lee, J.Y. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clin Exp Res 1993, 17: 234-40.
68. Shaw, G.K., Waller, S., Majumdar, S.K., Latham, C.J., Dunn, G. Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 1994, 165: 515-23.
69. Tamion, F., Petit, J., Massari, P., Leroy, J., Biga, N., Oksenhendler, G. Malignant neuroleptic syndrome during tiapride treatment. J Toxicol Clin Exp 1990, 10: 461-7.
70. Delmeire, F. Tiapridal. Acta Psychiatr Belg 1980, 80: 191-201.
71. 3 receptor agonist. Nature (Lond) 1999, 400: 371-5.
72. Cohen, C., Perrault, G., Sanger, D.J. Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats. Psychopharmacology 1998, 140: 478-85.
73. 3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processed in mice. Eur J Pharmacol 1997, 324: 147-51.
74. Gyertyan, I., Gal, K. Dopamine D3 receptor ligands show place conditioning effects but do not influence cocaine-induced place preference. NeuroReport 2003, 14: 93-8.
75. Silvestre, J.S., O'Neill, M.F., Fernandez, A.G., Palacios, J.M. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat. Eur J Pharmacol 1996, 318: 257-65.
76. Meert, T.F., Clincke, G.H. 7-OH-DPAT and alcohol consumption, withdrawal and discriminative stimulus properties. Alcohol Alcohol 1994, 29: 489-92.
77. Boyce, J.M., Risinger, F.O. Enhancement of ethanol reward by dopamine D3 receptor blockade. Brain Res 2000, 880: 202-6.
78. 3 receptor antagonist effects on the motivational effects of ethanol. Alcohol 2002, 28: 47-55.
79. 3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 1998, 287: 187-97.
80. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm Gen Sect 1994, 98: 39-55.
81. Xu, M., Koeltzow, T.E., Cooper, D.C., Tonegawa, S., White, F.J. Dopamine D3 receptor mutant mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 1999, 31: 210-5.
82. Narita, M., Soma, M., Tamaki, H., Narita, M., Suzuki, T. Intensification of the development of ethanol dependence in mice lacking dopamine D(3) receptor. Neurosci Lett 2002, 324: 129-32.
83. 3 receptors have spatial working memory deficits. J Neurosci 2002, 22: 5619-29.
84. Sautel, F., Griffon, N., Sokoloff, P. et al. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 1995, 275: 1239-46.
85. 3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 2000, 294: 1154-65.
86. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat. J Med Chem 2000, 43: 1878-85.
87. 3 receptors prevents nicotine-triggered relapse to nicotine seeking behavior. Neuropsychopharmacology 2003a, 28: 1272-80.
88. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28: 329-38.
89. 3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002, 22: 9595-603.
90. Ashby, C.R., Jr., Paul, M., Gardner, E.L., Heidbreder, C.A., Hagan, J.J. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 2003, 48: 154-6.
91. Rivera, S.N., Katana, J., Ashby, C.R., Jr. et al. A novel dopamine D3 receptor antagonist (SB-277011-A) attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. 33rd Annu Mtg Soc Neurosci (November 8-12, New Orleans) 2003, Abst. 665.7.
92. Andreoli, M., Marcon, C., Hagan, J.J., Heidbreder, C.A. Effect of selective antagonism at dopamine D3 receptor by SB-277011-A on oral alcohol self-administration in mice. Eur Neuropsychopharm 2003b, 13: S17.
93. Gilbert, J., Xi, Z.-X., Campos, A., Ashby, C.R., Jr., Hiedbreder, C.A., Gardner, E.L. The dopamine D3 receptor antagonist SB277011A inhibits cocaine reinforcement under fixed ratio and progressive ratio schedules. 33rd Annu Mtg Soc Neurosci (November 8-12, New Orleans) 2003, Abst. 422.10.